Graves Disease: all 162 studies
Page 1 of 2. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' DiseaseNot yet recruitingNCT07901244Phase 2/3
- Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye DiseaseRecruitingNCT07885605Phase 1
- Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)Not yet recruitingNCT07883356Phase 2
- Impact of Restrictive Diets on Inflammation and Quality of Life in Autoimmune ThyroiditisNot yet recruitingNCT07879690Not applicable
- Thyroid-Stimulating Hormone Receptor (TSHR) Blockade With REGN24493 in Adult Participants With Graves' Disease (GD)Not yet recruitingNCT07861152Phase 1
- AI-Based Wearable Monitoring (Glandy HYPER) for Antithyroid Drug Dose Adjustment in Graves' DiseaseNot yet recruitingNCT07857421Not applicable
- Thyroid Disorders in Pediatric Autoimmune HepatitisNot yet recruitingNCT07827235
- Early Risk Stratification of Thyroid Eye Disease in Newly Diagnosed Graves' DiseaseRecruitingNCT07812194
- Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)RecruitingNCT07753603Phase 3
- A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years OldRecruitingNCT07722546Phase 2
- Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry StudyRecruitingNCT07716397
- Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' DiseaseRecruitingNCT07682896Phase 2
- Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' DiseaseRecruitingNCT07661056Phase 3
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.RecruitingNCT07596849Phase 3
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' DiseaseRecruitingNCT07570316Phase 3
- Autoimmune Hyperthyroidism in Prepubertal ChildrenEnrolling by invitationNCT07544290
- Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves DiseaseRecruitingNCT07480720
- Telehealth Music Therapy for Adults With Endocrine Disorder and DepressionRecruitingNCT07413874Not applicable
- Impact of Thyroid Hormones on Human Glucose and Energy MetabolismRecruitingNCT07410637Not applicable
- Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune DiseaseRecruitingNCT07400224Phase 1/2
- In Vivo CAR-T for Refractory Graves' DiseaseRecruitingNCT07333677Early Phase 1
- NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' DiseaseRecruitingNCT07305818Phase 1
- A Study of GensSci098 in Subjects With Graves' DiseaseRecruitingNCT07286656Phase 1
- A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)Enrolling by invitationNCT07286006Phase 2
- Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' DiseaseRecruitingNCT07261345Early Phase 1
- Allogeneic Anti-CD19 CAR-T for Refractory Graves' DiseaseRecruitingNCT07129642Early Phase 1
- Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line TreatmentRecruitingNCT07117981
- Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.RecruitingNCT07059507
- Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid NodulesRecruitingNCT07046546Not applicable
- A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in ChinaRecruitingNCT07040306
- A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruitingNCT07018323Phase 2
- Evaluating an AI Tool for Detecting Thyrotoxic StatesRecruitingNCT07017907
- A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseRecruitingNCT06984627Phase 2
- Study of BHV-1300 in Graves' DiseaseRecruitingNCT06980649Phase 1
- Thyroidectomy for Graves' Disease or Amiodarone-induced ThyrotoxicosisRecruitingNCT06963203
- Prospective Evaluation of OptiThyDoseRecruitingNCT06864351Not applicable
- A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruitingNCT06727604Phase 2
- Iodine Supplementation in Graves' HyperthyroidismNot yet recruitingNCT06540469Not applicable
- Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid DisordersNot yet recruitingNCT06537141Not applicable
- A Prospective Evaluation of Microwave Ablation (MWA) in the Treatment of Relapsed Graves' DiseaseRecruitingNCT06506149Not applicable
- Graves' Disease Induced by Epstein-Barr Virus Lytic ReactivationNot yet recruitingNCT06426758
- Assessment of Thyroid Doppler Ultrasound in Followup of Pediatric Graves' DiseaseNot yet recruitingNCT06357494
- Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual CareNot yet recruitingNCT06327828Not applicable
- The Impact of Person Centred Care (PCC) in Grave's DiseaseRecruitingNCT06309316Not applicable
- The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid DysfunctionRecruitingNCT06275373
- Course for Brain Fatigue After Graves' Disease Controlled StudyRecruitingNCT06134219Not applicable
- Validating Immunological Markers Associated With Mental Fatigue in Graves' DiseaseRecruitingNCT06081439
- Graves' Disease Remission Study: MycoMeth ComboRecruitingNCT06068179Phase 2/3
- Clinical and Surgical Outcomes of Total Thyroidectomy in Basedow's Disease: the Effect of Lugol SolutionEnrolling by invitationNCT05784792Not applicable
- Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves DiseaseRecruitingNCT05643365
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT05635266
- Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' DiseaseRecruitingNCT05461820Phase 4
- Preoperative Corticosteroids in Autoimmune Thyroid DiseaseRecruitingNCT05435547Phase 4
- A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)CompletedNCT06384547Phase 3Results posted
- An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301CompletedNCT06179875Phase 3Results posted
- An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)CompletedNCT06021054Phase 3Results posted
- A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' DiseaseCompletedNCT05907668Phase 2Results posted
- A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)CompletedNCT05176639Phase 3Results posted
- Preoperative Steroids in Autoimmune Thyroid DiseaseCompletedNCT04542278Phase 4Results posted
- Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?TerminatedNCT04080505Phase 3Results posted
- Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease PatientsCompletedNCT02993302Phase 2Results posted
- ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid TherapyCompletedNCT02973802Phase 1Results posted
- A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' DiseaseCompletedNCT02713256Phase 2Results posted
- Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and ParathyroidectomyCompletedNCT02205801Not applicableResults posted
- Early Levothyroxine Post Radioactive IodineCompletedNCT01950260Phase 2/3Results posted
- Radioactive Iodide Therapy for Pediatric Graves' DiseaseCompletedNCT01269749Phase 2Results posted
- Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves DiseaseCompletedNCT00946296Phase 4Results posted
- Microbiota and Immune SignatureS of Graves' Disease and OrbitopathyActive, not recruitingNCT07870161Not applicable
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' DiseaseActive, not recruitingNCT07369063Phase 2
- Incidence of Graves' Disease After COVID-19 VaccinationActive, not recruitingNCT07213141
- Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' DiseaseCompletedNCT07164079Not applicable
- BASE-DIET: a Study on Nutritional Intervention in Patients With Graves' DiseaseActive, not recruitingNCT06921304Not applicable
- Cardiac Symptoms in Patients With Treated Graves' DiseaseActive, not recruitingNCT06908369
- Effects of Vitamin D Supplementation on Muscle Function Among Grave's Disease PatientsCompletedNCT06451016Not applicable
- A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.Active, not recruitingNCT06418919Not applicable
- Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)CompletedNCT06367517
- Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dzSuspendedNCT06240455Phase 2
- To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With HyperthyroidismStatus unknownNCT06204393
- A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye DiseaseActive, not recruitingNCT06088979Phase 2
- Efficacy of Methimazole Dosing AlgorithmTerminatedNCT05964452
- Exploring Accessible Beauty for Individuals With Upper Extremity DeficitsCompletedNCT05945784
- Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid SurgeryWithdrawnNCT05774535
- TSI and Its Relationship With Graves' Disease RelapseCompletedNCT05713097
- Exploring Immunological Markers Associated With Mental Fatigue in Graves' DiseaseTerminatedNCT05678374
- Three-dimensional Ultrasonography Thyroid Volume Measurement.Status unknownNCT05510609Not applicable
- Antithymocyte Globulin as a Second Line Therapy in Graves OrbitopathyStatus unknownNCT05199103Not applicable
- Hydroxychloroquine in Mild Graves' OrbitopathyActive, not recruitingNCT05126147Phase 4
- Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of AtherosclerosisCompletedNCT05118542Phase 3
- The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicCompletedNCT05098600
- Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of HyperthyroidismCompletedNCT04932135
- Tocilizumab in Active Moderate-severe Graves' OrbitopathyCompletedNCT04876534Phase 2
- Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-upStatus unknownNCT04789993
- Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side EffectsCompletedNCT04686006
- Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid DiseaseCompletedNCT04682340
- Heart Rhythm After Intravenous Methylprednisolone AdministrationCompletedNCT04391439
- Change of Gut Microbiome in the Treatment of Graves' DiseaseCompletedNCT04383795
- Heart Rate Monitoring by Wearable Devices in Graves' DiseaseStatus unknownNCT04333342Not applicable
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
- The Relationship Between NK Cell and Graves' DiseaseStatus unknownNCT04135573
- Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease.CompletedNCT03980132Phase 4